REG - UBS ETFs - AGM Statement

CS SAAnnouncement

16/03/2022 10:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220315:nRSO7065Ea&default-theme=true

RNS Number : 9643E  UBS ETFs  16 March 2022

UBS (Lux) Fund Solutions
Société d'Investissement à Capital Variable (SICAV)

Registered office: 49, avenue J.F. Kennedy, L-1855 Luxembourg

R.C.S. Luxembourg: no. B 83626

 

 

ANNUAL GENERAL MEETING

 

 

Notice is hereby given to the shareholders of UBS (Lux) Fund Solutions (the
"Company") that the ANNUAL GENERAL MEETING of the shareholders of the Company
will be held at the registered office of the Company at 49, avenue J.F.
Kennedy, L-1855 Luxembourg on 19 April 2022 at 11.30 a.m. with the following
agenda:

 

AGENDA

 

1.       Presentation and approval of the Reports of the Board of
Directors and of the Independent Auditors;

2.       Approval of the Financial Statements for the accounting year
ended 31 December 2021;

3.       Allocation of the results and approval of the dividend
distributions by the Company;

4.       Discharge to the Board of Directors in relation to the
performance of their duties during the accounting year ended 31 December 2021;

5.       Statutory Elections:

a)       To appoint Mrs. Josée Lynda Denis as Independent Director for
a two-year term, until the annual general meeting to be held in 2024.

b)      Re-appointment of Ernst & Young S.A. as independent Auditor
of the Company until the next annual general meeting of shareholders to the
held in 2023;

6.       Miscellaneous.

 

 

Copies of the latest version of the Annual Report are available free of charge
during normal office hours at the registered office of the Company in
Luxembourg or on the Internet website of the Company (www.ubs.com/etf
(http://www.ubs.com/etf) ) as of April 8(th) , 2022.

 

For shareholders who are holding shares in the Company through a financial
intermediary or clearing agent e. g. the bank where they safekeep their
shareholding, it should be noted that:

-  the proxy form must be returned to the financial intermediary or clearing
agent e.g.. the bank where they safekeep their shareholding in good time for
onward transmission to the Company by  April 12, 2022.

 

There will be no requirement as to the quorum in order for the general meeting
to validly deliberate and decide on the matters listed in the agenda;
resolutions will be passed by the simple majority of the shares present or
represented at the meeting. At the annual shareholders' meeting, each share
entitles to one vote.

 

The majority at the AGM will be determined according to the shares issued and
outstanding at midnight (Luxembourg time) on the fifth day prior to the AGM
(i.e. April 14, 2022) (the "Record Date"). The rights of a shareholder to
participate at the AGM and to exercise a voting right attaching to his/her/its
shares are determined in accordance with the shares held by this shareholder
at the Record Date.

 

Due to the exceptional circumstances of the Coronavirus COVID-19 and the
measures taken by the Luxembourg government, shareholders who would like to
participate to the General Meeting are required to do so by completing and
signing either the voting form or the proxy form enclosed for your
convenience.

No in-person attendance to the Annual General Meeting is possible.

 

Only those shareholders who are holding their shares by being directly
registered in the Company´s share register should send either the enclosed
Form of Proxy or Voting Form by e-mail to
Luxembourg-Domiciliarygroup@statestreet.com and/or by fax to +352 46 40 10 413
no later than 13 April 2022 close of business in Luxembourg.

The original Form of Proxy or Voting Form as applicable shall then be sent by
mail to the registered office of the Company (Attn. Domiciliary Services).

 

 

Proxy forms and Voting forms may be obtained by simple request at the same
address.

 

 

 

Luxembourg, March 15, 2022

By Order of the Board of Directors

UBS (Lux) Fund Solutions

Société d'Investissement à Capital Variable (SICAV)

Registered office: 49, avenue J.F. Kennedy, L-1855 Luxembourg

R.C.S. Luxembourg: no. B 83626

 

 

 

 

FORM OF PROXY

 

 

 

I/we ________________________the undersigned,

herewith give proxy for _____________________ /all my/our shares of

 

 

UBS (Lux) Fund Solutions (the "Company")

 

to the Chairman of the shareholders' meeting with full power of substitution
to exercise on my/our behalf the voting rights relating to my/our shares at
the Annual General Meeting of the shareholders of UBS (Lux) Fund Solutions to
be held in Luxembourg on 19 April 2022 at 11.30 a.m. (Luxembourg time) and at
any meeting to be held thereafter for the same purpose, with the same agenda,
to act and vote on the matters set out in the following agenda:

 

 

AGENDA

 

1.          FOR ¥ AGAINST ¥
Presentation and approval of the Reports of the Board of Directors

            ABSTAIN
¥                             and of the
Independent Auditors;

 

2.          FOR ¥ AGAINST ¥

            ABSTAIN
                             Approval of the
Financial Statements for the accounting year ended

31 December 2021;

 

3.          FOR ¥ AGAINST ¥

ABSTAIN                              Allocation
of the results and approval of the dividend distributions by the Company;

 

4.          FOR ¥ AGAINST ¥

ABSTAIN                              Discharge
to the Board of Directors in relation to the performance of their duties
during the accounting year ended 31 December 2021;

 

5 a.        FOR ¥ AGAINST ¥

            ABSTAIN
                             Appointment of
Mrs. Josée Lynda Denis as Independent Director for a two-year term, until the
annual general meeting to be held in 2024;

 

5 b.       FOR ¥ AGAINST ¥

            ABSTAIN
                             Re-appointment of
Ernst & Young S.A. as Independent Auditor of the Company until the next
annual general meeting of shareholders to be held in 2023.

 

 

 

 

 

 

I/we hereby give and grant full power and authorization to do and perform all
and everything necessary or incidental to the exercise of the powers herein
specified and we hereby ratify and confirm that said proxy shall lawfully do
or cause to be done by virtue hereof.

 

 

 

 

 

Signed:
 
            Date:
 
 

 

 

 

 

UBS (Lux) Fund Solutions

Société d'Investissement à Capital Variable (SICAV)

Registered office: 49, avenue J.F. Kennedy, L-1855 Luxembourg

R.C.S. Luxembourg: no. B 83626

 

 

VOTING FORM

 

 

 

The undersigned_______________________________________,

 

Holder of_____________________________________________ shares of

 

UBS (Lux) Fund Solutions (the "Company")

 

Hereby declares that he/she/ it is not attending in person to the Annual
General Meeting of the shareholders of UBS (Lux) Fund Solutions to be held in
Luxembourg on  19 April 2022 at 11.30 a.m (Luxembourg time) and at any
meeting to be held thereafter for the same purpose, with the following agenda:

 

 

AGENDA

 

1.   Presentation and approval of the Reports of the Board of Directors and
of the Independent Auditors;

2.   Approval of the Financial Statements for the accounting year ended 31
December 2021;

3.   Allocation of the results and approval of the dividend distributions by
the Company;

4.   Discharge to the Board of Directors in relation to the performance of
their duties during the accounting year ended 31 December 2021;

5.   Statutory Elections:

 

a.   To appoint Mrs. Josée Lynda Denis as Independent Director for a
two-year term, until the annual general meeting to be held in 2024.

b.   Re-appointment of Ernst & Young S.A. as independent Auditor of the
Company until the next annual general meeting of shareholders to the held in
2023;

6.   Miscellaneous.

 

 

The undersigned hereby votes as follow on the proposed resolutions of the
Annual General Meeting of the shareholders:

 

1.   Presentation and approval of the Reports of the Board of Directors and
of the Independent Auditors:

 

FOR       AGAINST        ABSTAIN 

 

 

2.   Approval of the Financial Statements for the accounting year ended 31
December 2021:

 

FOR        AGAINST       ABSTAIN 

 

 

3.   Allocation of the results and approval of the dividend distributions by
the Company:

 

FOR        AGAINST       ABSTAIN 

 

 

4.   Discharge to the Board of Directors in relation to the performance of
their duties during the accounting year ended 31 December 2021:

 

FOR        AGAINST       ABSTAIN 

 

 

5.     Statutory Elections

 

a.         Appointment of Mrs. Josée Lynda Denis as Independent
Director for a two-year term, until the annual general meeting to be held in
2024:

 

FOR        AGAINST       ABSTAIN 

 

b.         Re-appointment of Ernst & Young S.A. as independent
Auditor of the Company until the next annual general meeting of shareholders
to the held in 2023:

 

FOR        AGAINST       ABSTAIN 

 

 

 

 

 

 

 

 

 

 

Signed:
 
            Date:
 
 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  AGMUNVKRURUOARR